Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry

Biomarker changes between primary (PT) and metastatic tumor (MT) site may be significant in individualizing treatment strategies and can result from actual clonal evolution, biomarker conversion, or technical limitations of diagnostic tests. This study explored biomarker conversion during breast can...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Stefanovic, Stefan, Wirtz, Ralph, Deutsch, Thomas M., Hartkopf, Andreas, Sinn, Peter, Varga, Zsuzsanna, Sobottka, Bettina, Sotiris, Lakis, Taran, Florin-Andrei, Domschke, Christoph, Hennigs, Andre, Brucker, Sara Y., Sohn, Christof, Schuetz, Florian, Schneeweiss, Andreas, Wallwiener, Markus
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584258/
https://ncbi.nlm.nih.gov/pubmed/28881657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items